Ionis Pharma’s Steven Hughes Joins Organovo as Chief Medical Officer

Steven Hughes has joined Organovo (NASDAQ: [[ticker:ONVO]]) to serve as the San Diego company’s chief medical officer. Hughes comes to Organovo from Carlsbad, CA-based Ionis Pharmaceuticals (NASDAQ: [[ticker:IONS]]), where he was chief clinical development officer. His experience also includes senior leadership roles at Biogen (NASDAQ: [[ticker:BIIB]]), CSL Behring, and Sanofi (NYSE: [[ticker:SNY]]). Organovo has several preclinical programs being developed as treatments for liver conditions.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.